Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico
Author(s) -
Cosme AlvaradoEsquivel,
Manuela de la Ascensión Carrera-Gracia,
Carlos J Conde-González,
Luis JuárezFigueroa,
Lilia Ruiz-Maya,
Sergio AguilarBenavides,
Alejandro Torres-Valenzuela,
Erwin Sablon
Publication year - 2005
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki457
Subject(s) - hbsag , virology , hepatitis b virus , lamivudine , genotype , hepatitis b , virus , orthohepadnavirus , hepadnaviridae , biology , medicine , gene , genetics
Drug resistance of hepatitis B virus (HBV) is an increasing clinical problem. Resistance to lamivudine in HBV isolates in Mexico has been poorly explored.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom